10349. Adulteration and misbranding of Bragg B Forto-Fide Tablets. IT. S. v. 
894 Dozen Bottles of Bragg B Forto-Fide Tablets. Consent decree of 
condemnation.    Product  ordered  released under bond.     (F.  D.  C.   No.
17529.    Sample No. 16054-H.)
containing 195 tablets, and 7 dozen bottles, each containing 400 tablets, of Bragg 
B Forto-Fide Tablets at Chicago, Ill.* These tablets contained less than the 
declared amount of vitamin Ba, and 4 tablets would not provide the minimum 
daily adult or child's requirement for vitamin B2, as claimed on the label.
LABEL IN PART:   "Bragg B Forto-Fide."
NATURE OE CHARGE: Adulteration, Section 402 (b) (1), a valuable constituent, 
vitamin B2 (riboflavin), had been in part omitted from the article.
Misbranding, Section 403 (a), the statements on the label, "Four Tablets 
(the suggested daily ration) provide * * * Vitamin B2—2 Mg. (2000 
micrograms) * * * Four tablets provide the minimum daily adult or 
child's requirements of vitamin B2," were false and misleading.
DISPOSITION : August 21, 1946. The W. T. Thompson Co., Los Angeles, Calif., 
claimant, having consented to the entry of a decree, judgment of condemnation 
was entered and the product was ordered released under bond for segregation 
and relabeling in conformity with the law, under the supervision of the Federal 
Security Agency.